Cargando…

Spiralyde A, an Antikinetoplastid Dolabellane from the Brown Alga Dictyota spiralis

Bioassay-guided fractionation of the antikinetoplastid extract of the brown alga Dictyota spiralis has led to the isolation of spiralyde A (1), a new dolabellane aldehyde, along with other five known related diterpenes (2–6). Their structures were determined by HRESIMS, 1D and 2D NMR spectroscopy, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiboub, Olfa, Sifaoui, Ines, Lorenzo-Morales, Jacob, Abderrabba, Manef, Mejri, Mondher, Fernández, José Javier, Piñero, José E., Díaz-Marrero, Ana R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471066/
https://www.ncbi.nlm.nih.gov/pubmed/30934651
http://dx.doi.org/10.3390/md17030192
Descripción
Sumario:Bioassay-guided fractionation of the antikinetoplastid extract of the brown alga Dictyota spiralis has led to the isolation of spiralyde A (1), a new dolabellane aldehyde, along with other five known related diterpenes (2–6). Their structures were determined by HRESIMS, 1D and 2D NMR spectroscopy, and comparison with data reported in the literature. The antiparasitic activity of all compounds was evaluated. Spiralyde A (1) and the known compound 3,4-epoxy-7,18-dolabelladiene (2) were the most active compounds against Leishmania amazonensis and Trypanosoma cruzi. Spiralyde A (1) was the most potent compound, comparable to benznidazole, the reference drug for trypanocidal activity.